PharmiWeb.com - Global Pharma News & Resources
03-Jun-2019

Nass Valley Gateway Ltd.: Nass Valley Gateway Ltd. Shares Started Trading on Frankfurt Stock Exchange Started After Successful Acquisitions

DGAP-News: Nass Valley Gateway Ltd. / Key word(s): IPO/Takeover

03.06.2019 / 14:21
The issuer is solely responsible for the content of this announcement.


Nass Valley Gateway Ltd. Shares Started Trading on Frankfurt Stock Exchange Started After Successful Acquisitions
 
Vancouver/Frankfurt - June 3, 2019
Nass Valley Gateway Ltd. (the "Company" or "Nass Valley"), a Canadian company that specializes in Durable Medical Equipment (DME) and Cannabidiol (CBD) related consumer products, has completed the acquisition of two companies: Advanced Bioceuticals Limited (ABL), incorporated under the Laws of New Jersey and Pro-Thotics Technology Inc. (PTI), a New York corporation with a more than 25 year established business. In this context, Nass Valley has issued 280,000,000 common shares as total consideration for the acquisitions which increased the total number of the issued and outstanding common shares to 312,143,477. Nass Valley's shares are trading on the Frankfurt Stock Exchange in the Open Market Segment, under the trading Symbol 3NVN, respectively ISIN CA6315202029.
 
Through its new subsidiary PTI the Company will continue to focus on expanding the sale of DME-Products and increasing its database of more than 200,000 patients with service of providing relief from pain via its DME-Products. Through its subsidiary ABL the Company is determined to expand upon this pain relief concept, leverage the patient database and commence the sale of Cannabidiol (CBD) with zero Tetrahydrocannabinol (THC) content for internal use as well as CBD infused skin, bath, and body care products.
 
Currently, the Company primarily engages in the sale of DME-Products. Nass Valley plans to generate substantial additional sales through the marketing and sale of new CBD containing products. The Company's current database of more than 200,000 patients as well as its proprietary technology allows for diversification into the CBD market, devoted to patients across the globe.
 
Together with a team of chemists and food technologists, Nass Valley intends to set up its own production facility and distribution channels for CBD products to keep full control of the supply chain and maximize both product quality and safety. In line with the firm's growth strategy, Nass Valley plans to open offices in Maryland, Virginia, California and Washington, DC.
 
Investor Relations Contact:
Maximilian Fischer, email: maximilian.fischer@kirchhoff.de Tel: +49 172 8241464    
About Nass Valley Gateway Ltd.

Nass Valley Gateway Ltd. specializes in the production and sale of Durable Medical Equipment for patients with chronical pain and the marketing and sale of Cannabidiol (CBD) related consumer products. Nass Valley was founded in 2005 and is headquartered in Vancouver, Canada. In 2019 the Company completed the acquisition of its two main subsidiaries: Pro-Thotics Technology Inc. (PTI) and Advanced Bioceuticals Limited (ABL). PTI is specialized in over the counter and custom orthotics dedicated to patients in need of products for chronic pain. ABL operates in the field of selling CBD related products for internal usage as well as skin care purposes.
 

03.06.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Nass Valley Gateway Ltd.
422 Richards Street, Suite 170
V6B 2Z Vancouver
Canada
Phone: +1 (604) 617-6794
E-mail: HQ@nassvalleygateway.com
Internet: www.nassvalleygateway.com
ISIN: CA6315202029
WKN: A1JVHM
Listed: Regulated Unofficial Market in Berlin, Frankfurt, Hamburg, Stuttgart; Toronto
EQS News ID: 818503

 
End of News DGAP News Service

Editor Details

Last Updated: 03-Jun-2019